The abstract is read at the publisher; the summary is JClub's.
Active granzyme A activity in stool supernatants is linked to gut inflammation in inflammatory bowel disease, improving identification of patients over existing tests in ~150 participants.
- Why it matters: Current IBD diagnosis and monitoring rely on histology, endoscopy, and generic inflammation markers, lacking specific readouts of T cell–mediated immune activity.
- What they did: The study detected increasing granzyme A in gut biopsies, then designed a peptide inhibitor–based chemiluminescence assay to measure active GzmA in stool supernatants from ~150 human patients with IBD and healthy controls.
- The result: Granzyme A activity is an indicator of gut inflammation that enhances patient identification and may serve as a mechanistic biomarker reflecting T cell dominance, supporting precision medicine approaches in IBD.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.